Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Clinical Nutrition (Edinburgh, Scotland)|April 11, 2024
The potential of machine learning models to identify malnutrition diagnosed by GLIM combined with NRS-2002 in colorectal cancer patients without weight loss informationTiantian Wu, Hongxia Xu, Wei Li, et al.The Journal of Nutrition, Health & Aging|January 12, 2024
Association of possible sarcopenia with all-cause mortality in patients with solid cancer: A nationwide multicenter cohort studyLiangyu Yin, Chunhua Song, Jiuwei Cui, et al.International Journal of Biological Sciences|October 20, 2022
Chronic Inflammation Pathway NF-κB Cooperates with Epigenetic Reprogramming to Drive the Malignant Progression of GlioblastomaKefeng Lin, Wenli Gao, Ning Chen, et al.BMC Cancer|February 8, 2025
Effect of comorbidity classes on survival of patients with gastrointestinal tract cancerLinna Gao, Tian Yao, Shaohua Ge, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 5, 2021
Is hand grip strength a necessary supportive index in the phenotypic criteria of the GLIM-based diagnosis of malnutrition in patients with cancer?Liangyu Yin, Xin Lin, Zhiping Zhao, et al.Cancer Medicine|May 21, 2024
The effect of liver metastases on clinical efficacy of first-line programmed death-1 inhibitor plus chemotherapy in esophageal squamous cell carcinoma: A post hoc analysis of ASTRUM-007 and meta-analysisJing Gao, Yan Song, Xiaoge Kou, et al.Cancer Immunology, Immunotherapy : CII|March 8, 2025
Effectiveness, safety, and patterns of use of camrelizumab in advanced esophageal cancer: an individual patient data pooled analysis of 987 patients from three prospective cohort studiesZhihao Lu, Guoping Sun, Jiancheng Li, et al.JPEN. Journal of Parenteral and Enteral Nutrition|January 8, 2021
Classification Tree-Based Machine Learning to Visualize and Validate a Decision Tool for Identifying Malnutrition in Cancer PatientsLiangyu Yin, Xin Lin, Jie Liu, et al.Nature Medicine|February 2, 2023
First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trialYan Song, Bo Zhang, Dao Xin, et al.Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|March 9, 2024
Value of the modified Patient-Generated Subjective Global Assessment in indicating the need for nutrition intervention and predicting overall survival in patients with malignant tumors in at least two organsFeifei Chong, Zhenyu Huo, Liangyu Yin, et al.Pageof 7